Clinical trial · Interventional
Strength Training and ADLs in Childhood Leukemia and Lymphoma Patients
Effects of a Specific Strength Training Regarding Activities of Daily Living (ADLs) Associated With Movement During Treatment of Leukemia or Non-Hodgkin Lymphoma in Childhood and Adolescence
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Reduced activity levels and reduced muscular strength could severely impair the activities of daily living (ADLs) in pediatric leukemia and Non-Hodgkin lymphoma patients. Increased muscle strength is associated with improved accomplishment of ADLs and consequently greatest possible normality, autonomy and mobility. Primary outcome of this RCT (n=20/20) is the analysis of effects of a treatment-associated and close to every day life strength training (2-3 times/week) compared to a general exercise program (standard care).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Childhood Cancer | Childhood Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Exercise | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention
- description
- Supervised exercise training including specific strength training tools and general exercise contents (standard care), 2-3 times per week, 30 minutes per session
- interventionNames
- Other: Exercise
- type
- NO_INTERVENTION
- label
- Control
- description
- Supervised exercise training regarding general exercise contents (standard care), 2-3 times per week, 30 min per session
Primary outcomes (1)
- measure
- Change of score of the Activities Scale for Kids - performance version
- timeFrame
- Change of the ASK score from baseline to 3 months, change from 3 months to 6 months, change from 6 months to 12 months
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 4 Years
- Maximum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosed with Acute Leukemia or Non-Hodgkin Lymphoma * Diagnosed and/or treated at the Kinderklinik München Schwabing, Technische Universität München * Informed consent as documented by signature Exclusion Criteria: * Medical contraindications regarding strength training (e.g. risk of bleeding, ...) * Contraindications to one of the inclusion criteria mentioned above * Inability to follow the procedures and understand the intervention and assessments of this study, e.g. due to cognitive impairment, language problems, psychological disorders etc.
References
Publications (0)
Data not yet available